# DiaMedica Therapeutics Inc. (DMAC) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from DiaMedica Therapeutics Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/DMAC/mda/fy2025/): filed 2026-03-30; accession 0001437749-26-010342 (https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm); latest 10-K
- [FY 2024 MD&A](/company/DMAC/mda/fy2024/): filed 2025-03-17; accession 0001437749-25-008018 (https://www.sec.gov/Archives/edgar/data/1401040/000143774925008018/dmtp20241231_10k.htm)
- [FY 2023 MD&A](/company/DMAC/mda/fy2023/): filed 2024-03-19; accession 0001437749-24-008522 (https://www.sec.gov/Archives/edgar/data/1401040/000143774924008522/dmtp20231231_10k.htm)
- [FY 2022 MD&A](/company/DMAC/mda/fy2022/): filed 2023-03-28; accession 0001437749-23-008189 (https://www.sec.gov/Archives/edgar/data/1401040/000143774923008189/dmtp20221231_10k.htm)
- [FY 2021 MD&A](/company/DMAC/mda/fy2021/): filed 2022-03-14; accession 0001437749-22-006163 (https://www.sec.gov/Archives/edgar/data/1401040/000143774922006163/dmtp20211231_10k.htm)

Back to /company/DMAC/